Sergio Lugo, MD
General Surgery · Wailuku, HINPI 1922285816
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $134 and has fallen 83.3% since, to $22 in 2025.
Across 16 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$95
- Amgen$88
- AstraZeneca$74
- Smith+Nephew$41
- Novocure Inc.$24
- Eisai Inc.$22
- plus $58 from 4 others
What the payments were for
- Food & beverage$403100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 1 | $95 |
| Amgen | 3 | $88 |
| AstraZeneca | 4 | $74 |
| Smith+Nephew | 2 | $41 |
| Novocure Inc. | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Argenx US, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
| AbbVie | 1 | $13 |
How this compares
Too few general surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 14 | $940 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 37 | $563 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $251 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $98 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Wailuku
- Beth JarrettWailuku$0
- Andrew TanWailuku$0
- Mihae YuHonolulu$37K
- Makoto OgiharaHonolulu$1K
- Susan SteinemannHonolulu$113
- John BalfourHonolulu$0
- Linda MiyashiroLihue$0
- Hao Chih HoHonolulu$0
- Junji MachiHonolulu$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.